AI beats the clock: new platform could speed up heart attack diagnosis

NCT ID NCT06939738

Completed Diagnosis Sponsor: Idoven 1903 S.L. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 21, 2026 · Updated 3 times

Summary

This study tests an artificial intelligence platform called Willem that analyzes electrocardiograms (ECGs) to detect heart attacks. Researchers will compare how fast and accurately the AI spots heart attack patterns versus human doctors. The study involves 500 adults who have had a heart attack and will look at whether the AI can speed up diagnosis and treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Willem (AI-powered ECG analysis platform)
What this could lead to: If successful, this AI could help doctors diagnose heart attacks faster and more accurately, potentially saving lives by speeding up treatment.
What could go wrong: This is an observational study, not a treatment trial. The AI may not perform better than human experts in real-world settings, and results may not apply to all hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDIAL INFARCTION (AMI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute myocardial infarction Non-ST Elevated Myocardial Infarction ST-elevation myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE MYOCARDIAL INFARCTION (AMI)

Contacts and locations

Locations

Germans Trias i Pujol University Hospital

Barcelona, 08916, Spain
Hospital General Universitario Gregorio Marañón

Madrid, 28007, Spain
La Paz University Hospital

Madrid, 28046, Spain
Unidade Local de Saúde de Lisboa Ocidental

Lisbon, 1449-005, Portugal
Unidade Local de Saúde de São José

Lisbon, 1169-056, Portugal

More trials for these conditions

Other studies related to the condition(s) this trial covers.